Catalyst Wire Dossier Catalyst Wire Dossier

ABVD

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ABVD, covering 2011-07-20 to 2021-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease [Phase 2]

See pricing